Literature DB >> 6974069

Effect of cyclosporin A on in vitro proliferative activity and immunoglobulin synthesis of isolated human lymphoid cell subpopulations.

T Paavonen, H Järveläinen, S Kontiainen, P Häyry.   

Abstract

Cyclosporin A inhibited at equal concentration both pokeweed mitogen and Staphylococcus aureus Cowan I-induced in vitro proliferative activity of blood leucocytes, intracellular immunoglobulin synthesis and release of immunoglobulin to the culture medium. When the interacting lymphoid cell subpopulations, T cells, B cells, T gamma and T micro cells were fractionated apart and separately stimulated with these mitogens, cyclosporin A inhibited again at equal concentrations pokeweed mitogen-induced proliferation of blood T gamma, T micro and B cells and Staphylococcus-induced proliferation of B cells. The 50% inhibitory concentration varied in separate experiments between 10(-2)-10(-1) microgram/ml. Although cyclosporin A efficiently suppressed the blastogenic response, a 100- to 1,000-fold concentration of the drug was required to damage resting lymphocytes in culture. After the blastogenic phase, pokeweed mitogen-stimulated blood leucocytes were again resistant to cyclosporin A: intracellular Ig synthesis and release of Ig to the culture medium proceeded independently of the presence of the drug. As the phagocytic activity of mononuclear phagocytes was not affected by prior culture in cyclosporin A-containing medium, we conclude that in man cyclosporin A suppression both T and B lymphocyte blastogenesis, and that the suppression is due to a direct effect on the blast cell rather than mediated via a third-party accessory cell.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6974069      PMCID: PMC1537293     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.

Authors:  D J White; A M Plumb; G Pawelec; G Brons
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

3.  Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen.

Authors:  L Moretta; M C Mingari; A Moretta; M D Cooper
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

4.  Antigen-induced proliferation of guinea pig lymphocytes in vitro: obligatory role of macrophages in the recognition of antigen by immune T-lymphocytes.

Authors:  J A Waldron; R G Horn; A S Rosenthal
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

5.  Nature of the unresponsiveness induced by cyclosporin A in rats bearing renal allografts.

Authors:  W P Homan; J W Fabre; P J Morris
Journal:  Transplantation       Date:  1979-11       Impact factor: 4.939

6.  Characterization of the role of mononuclear cell subpopulations in the in vitro lymphocyte proliferation assay.

Authors:  R C Gehrz; S O Knorr
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

7.  Lymphocyte stimulation by protein A of Staphylococcus aureus.

Authors:  A Forsgren; A Svedjelund; H Wigzell
Journal:  Eur J Immunol       Date:  1976-03       Impact factor: 5.532

8.  A method of increased sensitivity for detecting single antibody-forming cells.

Authors:  A J Cunningham
Journal:  Nature       Date:  1965-09-04       Impact factor: 49.962

9.  Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A.

Authors:  R Y Calne; D J White; K Rolles; D P Smith; B M Herbertson
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

10.  Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment.

Authors:  C J Green; A C Allison
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

View more
  8 in total

1.  Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.

Authors:  L H Block; P M Sutter; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-11-02

Review 2.  [Immunomodulatory therapy of autoimmune diseases : Quo vadis?].

Authors:  B F Hoyer; F Hiepe
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

3.  Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.

Authors:  J Woo; D J Propper; A W Thomson
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

4.  Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.

Authors:  A W Thomson; D K Moon; D S Nelson
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

5.  Effects of cyclosporin A on mouse lymphoid tissues.

Authors:  O Kai; R M Franklin
Journal:  Br J Exp Pathol       Date:  1983-10

6.  Cyclosporine inhibition of a murine B cell lymphoma.

Authors:  D S Pisetsky; G Haughton
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

Review 7.  Cyclosporine: immunology, toxicity and pharmacology in experimental animals.

Authors:  A W Thomson; P H Whiting; J G Simpson
Journal:  Agents Actions       Date:  1984-10

8.  Selective suppression of an early step in human B cell activation by cyclosporin A.

Authors:  A Muraguchi; J L Butler; J H Kehrl; R J Falkoff; A S Fauci
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.